![NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022 in: Journal of the National Comprehensive Cancer Network Volume 21 Issue 1 (2023) NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022 in: Journal of the National Comprehensive Cancer Network Volume 21 Issue 1 (2023)](https://jnccn.org/view/journals/jnccn/21/1/full-jnccn2101glinsfx5.jpg)
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022 in: Journal of the National Comprehensive Cancer Network Volume 21 Issue 1 (2023)
![Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance - ScienceDirect Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661821003649-ga1.jpg)
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance - ScienceDirect
dBRWD3 Regulates Tissue Overgrowth and Ectopic Gene Expression Caused by Polycomb Group Mutations | PLOS Genetics
![BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression | Cell Death & Disease BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2012.153/MediaObjects/41419_2012_Article_BFcddis2012153_Fig1_HTML.jpg)